Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Januar 2024

Genmab — Januar 2024

Planlagt Fastgjort Låst Flyttet Genmab
1.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #1142

    ok, thanks, i thought i had heard here before it was longer in denmark -my bad

    1 Reply Last reply
    0
    • P Offline
      P Offline
      Plimsoller
      wrote on sidst redigeret af
      #1143

      @Bulder Da de også er listet i USA, så er det vel de 4 uger der trumfer Genmab's egne vedtægter (som de derfor bør ændre), og derfor gælder?

      1 Reply Last reply
      0
      • P Offline
        P Offline
        Plimsoller
        wrote on sidst redigeret af
        #1144

        Spørgsmålet om deres udmeldinger i denne periode kommer op hvert eneste år her på chatten, så nu har jeg spurgt dem inde på IR. Det vil jo i givet fald forklare hvorfor vi ikke har hørt noget.

        1 Reply Last reply
        0
        • JørgenVarnæsJ Offline
          JørgenVarnæsJ Offline
          JørgenVarnæs
          wrote on sidst redigeret af
          #1145

          Isn’t this in line with common GEN IR practise? Since Rachel left GEN has shown precious little interest (bordering to sweet FA) for retail investors.

          1 Reply Last reply
          0
          • P Offline
            P Offline
            Plimsoller
            wrote on sidst redigeret af
            #1146

            Let's see JV. If I get
            a reply I will of course share.

            1 Reply Last reply
            0
            • JørgenVarnæsJ Offline
              JørgenVarnæsJ Offline
              JørgenVarnæs
              wrote on sidst redigeret af
              #1147

              Thx

              1 Reply Last reply
              0
              • BulderB Offline
                BulderB Offline
                Bulder
                wrote on sidst redigeret af
                #1148

                Dem der gerne vil have aktien, de køber alle på lukkeauktionen.

                1 Reply Last reply
                0
                • L Offline
                  L Offline
                  lahn1
                  wrote on sidst redigeret af
                  #1149

                  Er der mig, eller var der liiidt styrke i aktien idag ? Vil være dejlig hvis vi kan komme i 2000 inden regnskab og få en buffer ned til 1901 når markedet bliver åhh så overraskede over ny højere omkostninger til de mange ph3 trials

                  1 Reply Last reply
                  0
                  • W Offline
                    W Offline
                    w
                    wrote on sidst redigeret af
                    #1150

                    Kan være markedet har ændret holdning til dyre fase 3 forsøg i positiv retning,
                    efter voldgiften

                    1 Reply Last reply
                    0
                    • SolsenS Offline
                      SolsenS Offline
                      Solsen
                      wrote on sidst redigeret af
                      #1151

                      Mon ikke man vil nervøs indtil regnskab og specielt guidance foreligger. Man anser jo R&D for en katastrofe.

                      1 Reply Last reply
                      0
                      • L Offline
                        L Offline
                        lahn1
                        wrote on sidst redigeret af
                        #1152

                        Jo fase 3 forsøgene er jo en nødvendighed, særligt nu da voldgiften er tabt og burde blive belønnet som et fremskridt. Gmab skal jo bare huske at highlighte deres succesrate. Så bliver det jo så godt som money in the bank 🙂 Men guidance skal helst bekræfte den fortsat kraftige vækst

                        1 Reply Last reply
                        0
                        • B Offline
                          B Offline
                          bikube
                          wrote on sidst redigeret af
                          #1153

                          Både Genmab og Novo fortsatte op i USA

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #1154

                            from
                            Scancell Interim Results for the six months ended 31 October 2023- Antibodies:
                            • Development of SC129, out licensed to Genmab, continues on track towards potential clinical
                            development.
                            https://www.scancell.co.uk/Data/Sites/1/media/publications/rns/2024/scancell-interim-results-31-october-2023.pdf

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #1155

                              Novel Cervical Cancer Treatments in Clinical Trial https://news.med.miami.edu/novel-cervical-cancer-treatments-in-clinical-trial/ “The antibody drug conjugate tisotumab vedotin-tftv has also gained approval and became a standard-of-care therapy this year. This therapy extends survival significantly,” said Dr. Sinno.

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #1156

                                Pfizer
                                earnings later today will give us full year Tiso sales

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #1157

                                  Tivdak had list price changes this year of 3,90% 30-3-2023
                                  and 3,90%
                                  28-9-2023

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #1158

                                    so, pfizer reports $4mn for Tivdak under Represents revenues from legacy Seagen products subsequent to the acquisition on December 14, 2023. So now we have to find the remainder of the quarter 4 sales somewhere lol, Seagen doesn't report anymore

                                    1 Reply Last reply
                                    0
                                    • M Offline
                                      M Offline
                                      M_T_A
                                      wrote on sidst redigeret af
                                      #1159

                                      Pfizer skriver at FDA har accepteret Tivdak sBLA ansøgning om konvertering fra "accelerated approval" til fuld godkendelse med priority review og PDUFA dato d. 9 maj, se link side 8. 2024.https://s28.q4cdn.com/781576035/files/doc_financials/2023/q4/Q4-2023-PFE-Earnings-Release.pdf

                                      1 Reply Last reply
                                      0
                                      • L Offline
                                        L Offline
                                        lahn1
                                        wrote on sidst redigeret af
                                        #1160

                                        Håber det giver himmelfart til kursen 🙂

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          Plimsoller
                                          wrote on sidst redigeret af
                                          #1161

                                          Svar fra Andrew Carlsen angående stilleperioden "Our quiet period before earnings is still 2 weeks and has not been extended to 4 weeks with the US listing."

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper